文献速递瘢痕与激光创面修复

外源性PRAS40通过抑制mTORC1降低KLF4表达并减轻增生性瘢痕纤维化与胶原沉积

Exogenous PRAS40 reduces KLF4 expression and alleviates hypertrophic scar fibrosis and collagen deposition through inhibiting mTORC1.
PubMed 文献 · Burns · 2024-02-06

该研究在大鼠增生性瘢痕模型中局部注射PRAS40过表达腺病毒、mTORC1抑制剂MHY1485和激活剂雷帕霉素,通过HE、Masson及天狼星红染色观察皮肤组织病理与纤维化程度,并用蛋白质印迹和免疫荧光分析α-SMA与I型胶原沉积。结果显示PRAS40过表达可抑制瘢痕皮肤纤维化、减少α-SMA和I型胶原含量,其抗纤维化作用与抑制mTORC1激活有关,且PRAS40上调KLF4表达亦与mTORC1相关。

要点

  • 瘢痕皮肤组织中PRAS40表达低而p-PRAS40表达高。
  • 局部注射PRAS40过表达腺病毒可升高皮肤组织PRAS40表达并抑制瘢痕纤维化。
  • PRAS40的抗纤维化作用依赖于抑制mTORC1激活。

核心结论

  • PRAS40显著改善瘢痕皮肤组织纤维化并增加瘢痕中KLF4的表达,其抗纤维化作用依赖于mTORC1。

研究设计与样本

  • 研究构建大鼠增生性瘢痕模型,局部注射PRAS40过表达腺病毒、mTORC1抑制剂MHY1485和激活剂雷帕霉素,采用HE、Masson及天狼星红染色观察皮肤组织病理改变与纤维化严重程度,并用蛋白质印迹和免疫荧光检测α-SMA与I型胶原沉积,同时分析KLF4与α-SMA及I型胶原的共定位以及PRAS40对KLF4的调控作用。

主要发现

  • 瘢痕皮肤组织中PRAS40表达低而p-PRAS40表达高。
  • 局部注射PRAS40过表达腺病毒后皮肤组织PRAS40表达升高,过表达PRAS40可抑制瘢痕皮肤纤维化并降低α-SMA和I型胶原含量。
  • 机制分析证实PRAS40对皮肤纤维化的抑制作用与mTORC1相关,PRAS40抑制mTORC1的激活。
  • 瘢痕组织中KLF4表达相对较低,给予PRAS40可上调KLF4表达,且该上调与mTORC1相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To identify the anti-fibrosis effect of PRAS40 in scar, and its potential mechanism. METHODS: We constructed a rat model of hypertrophic scarthat was locally injected the PRAS40 overexpression adenoviruses, mTORC1 inhibitor MHY1485 and activator rapamycin, and further observed the pathological changes of skin tissue and the severity of fibrosis by HE, Masson and sirius red staining, and analyzed the deposition of a-SMA and collagen I by western blot and immunofluorescence test. Meanwhile, the co-localization of KLF4 with a-SMA and type I collagen was analyzed, as well as the regulatory effect of PRAS40 on KLF4. In addition, we also verified whether the inhibition of scar fibrosis by PRAS40 is related to mTORC1, and whether the upregulation of KLF4 is related to mTORC1. RESULTS: The results showed that the expression of PRAS40 was low and p-PRAS40 was high in scar skin tissue. After local injection of PRAS40 overexpression adenovirus, the expression of PRAS40 in skin tissue was increased. The overexpression of PRAS40 can inhibit scar skin fibrosis and reduce the content of a-SMA and collagen I. Further mechanism analysis confirms that the inhibitory effect of PRAS40 on skin fibrosis is related to mTORC1, and PRAS40 inhibits the activation of mTORC1. The expression of KLF4 is relatively low in scar tissue. PRAS40 administration upregulated the expression of KLF4, which is related to mTORC1 CONCLUSIONS: PRAS40 significantly improves fibrosis of scar skin tissue and increases the expression of KLF4 in scars. The anti-fibrotic effect of PRAS40 depends on mTORC1.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Wang C, Jiang D. Exogenous PRAS40 reduces KLF4 expression and alleviates hypertrophic scar fibrosis and collagen deposition through inhibiting mTORC1. Burns. 2024. PMID: 38369439. doi:10.1016/j.burns.2024.01.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。